Healthcare: reloaded...
5.4K views | +15 today
Follow
Healthcare: reloaded...
On the general trends in healthcare, low signals and tectonic moves, those who will shape the contour of the healthcare revolution...
Curated by Beeyond
Your new post is loading...
Your new post is loading...
Scooped by Beeyond
Scoop.it!

The Highest Health Care Cost In America May Surprise You

The Highest Health Care Cost In America May Surprise You | Healthcare: reloaded... | Scoop.it
The United States spent an estimated $201 billion on mental disorders like anxiety and depression in 2013, according to the new analysis published in the journal Health Affairs. That makes it the costliest medical condition in the country.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Inhaler could replace diabetic injections

Inhaler could replace diabetic injections | Healthcare: reloaded... | Scoop.it

Diabetes sufferers may soon be able to inhale life-saving drugs rather than having to give themselves several daily injections, according to published research.
An American study of a new inhaler device for insulin found that it worked as well as the traditional method of injections.
The findings could offer hope to diabetes sufferers who have to go through the discomfort and inconvenience of two or three daily jabs to maintain their blood glucose levels.

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Personalized medicine called not quite ready for primetime

Personalized medicine called not quite ready for primetime | Healthcare: reloaded... | Scoop.it
“There’s no such thing as personalized medicine in action,” said Dr. Laura Esserman, director of the University of California, San Francisco’s Carol Franc Buck Breast Care Center. In other words, Esserman explained, there has been an “incredible absence in clinical performance” of genomic medicine.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes

How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes | Healthcare: reloaded... | Scoop.it
In August 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Within days, Turing contacted Patient Services Inc., or PSI, a charity that helps people meet the insurance copayments on costly drugs. Turing wanted PSI to create a fund for patients with toxoplasmosis, a parasitic infection that is most often treated with Daraprim.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Superbugs could kill 10 million people a year by 2050, report warns

Superbugs could kill 10 million people a year by 2050, report warns | Healthcare: reloaded... | Scoop.it
In July 2014, the UK government commissioned the Review on Antimicrobial Resistance (AMR) to address the ever-growing concern that superbugs, resistant to current antibiotics, could eventually evolve to the point that our drugs simply don't work. The report's findings were released this week, including a comprehensive action plan to prevent the world being "cast back into the dark ages of medicine."
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Can tech improve human interaction in the transactional healthcare environment?

Can tech improve human interaction in the transactional healthcare environment? | Healthcare: reloaded... | Scoop.it

“We know that health care industry is very transactional, and we want to inject empathy,” Amy Cueva, founder and chief experience officer of Mad*Pow, told attendees at the Cleveland Clinic Patient Experience Summit this week.
“But the logistics of healthcare are difficult,” she acknowledged.

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Novartis To Split Company In Two!

Novartis To Split Company In Two! | Healthcare: reloaded... | Scoop.it
The Basel, Switzerland-based drug giant said Mr. Epstein, who is American, had decided to leave the company “to explore new challenges from the U.S.” Chief Executive Joe Jimenez said Mr. Epstein had “steered our pharmaceuticals division through a period of excellence in innovation, execution and improved financial results.”
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Tackling Indonesia’s diabetes challenge: Eight approaches from around the world

Tackling Indonesia’s diabetes challenge: Eight approaches from around the world | Healthcare: reloaded... | Scoop.it
Indonesia’s economic and demographic evolution is leading to a dramatic rise in noncommunicable diseases. How big is the problem? What approaches are other countries taking that could inform Indonesia’s response?
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Eversense 90-day Continuous Glucose Monitor CE Marked in Europe

Eversense 90-day Continuous Glucose Monitor CE Marked in Europe | Healthcare: reloaded... | Scoop.it
Senseonics, a company headquartered in Germantown, Maryland, won European regulatory clearance to introduce its Eversense continuous glucose monitoring system. The system includes a sensor that is implanted under the skin and swapped out for a new one every three months, and a transmitter that communicates with a matching smartphone app to provide the results.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Chinese firm intends to acquire French producer of pharmaceutical glass packaging

Chinese firm intends to acquire French producer of pharmaceutical glass packaging | Healthcare: reloaded... | Scoop.it

With a history of more than 100 years, SGD Pharma produces more than 2 billion glass containers per year and its recorded revenues last year reached 290 million euro (about $330 million). It owns manufacturing sites in Germany, France, China and India.
Established in 2014, the JIC is a long-term investor with major businesses operating in finance, investment, manufacture, real estate, and cultural services.

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Innovation Detractors in Pharma

Innovation Detractors in Pharma | Healthcare: reloaded... | Scoop.it

While many industries are blazing new trails in pursuit of new technologies, pharma appears to be lagging behind, often adopting a watch and wait approach. In most industries, the pace of technology change has increased so much that corporate IT leaders who don't embrace emerging trends end up behind the competition and eventually out of business. Can we really say the same is true for pharma companies?

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

5 Key Trends Driving Clinical Trial Innovation

5 Key Trends Driving Clinical Trial Innovation | Healthcare: reloaded... | Scoop.it
A recent study showed that two-thirds of a sample of 210 launches failed to meet pre-launch consensus sales expectations for their first year on the market. Coupled with evolving consumer experiences, business models and marketing approaches – organizations, specifically brand launch teams and marketing agencies, need to work together and refocus their strategies in order to cater to this shift and ensure a successful launch.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

HealthPopuli.com - Health/Care is Everywhere

HealthPopuli.com - Health/Care is Everywhere | Healthcare: reloaded... | Scoop.it
Pressures on the pharmaceutical industry are coming from every stakeholder touchpoint, driving companies to merge, set prices high for short-term gains, and (finally) put more resources toward providing patients services. Let’s call out just a few of the events from the past couple of weeks which, together, paint the current rocky landscape for pharma and life science companies: Last week on April 28th, termed “healthcare’s $45 billion day,” three big M&A deals hit the financial markets: Abbott sought to acquire St. Jude Medical (worth $30 bn alone), AbbVie looked to buy Stemcentrx for just under $6 bn, and Sanofi tagged
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Why does Covance have so many T2 Diabetes studies?

Why does Covance have so many T2 Diabetes studies? | Healthcare: reloaded... | Scoop.it
As the number of people diagnosed with type 2 increases, we are beginning to see how the condition fits into a wider health landscape. Driven by hectic modern lifestyles, we are all tending towards more ‘convenience’ food, which is often laden with sugar and fat. In the digital age, it is harder to detach from TV box-sets, video games, social media and email inboxes, and we’re generally leading less active lifestyles. Obesity is on the rise, and this is known to increase our chances of developing type 2 diabetes.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Samsung Targets U.S. Drug Market With Remicade Knockoff

Samsung Targets U.S. Drug Market With Remicade Knockoff | Healthcare: reloaded... | Scoop.it
Samsung Group said Tuesday its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration, marking the South Korean conglomerate’s first attempt to sell drugs to Americans, alongside its popular smartphones and televisions.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Drugmakers eye volume growth as China cuts prices by up to 67 percent

Drugmakers eye volume growth as China cuts prices by up to 67 percent | Healthcare: reloaded... | Scoop.it

Chinese health authorities announced price cuts of up to two-thirds for three drugs on Friday in the latest move to reduce the cost of healthcare for patients in the world's second-biggest economy.
The National Health and Family Planning Commission said the cost of GlaxoSmithKline's hepatitis B drug Viread would fall to 490 yuan ($75) a month from 1,500, and AstraZeneca's lung cancer pill Iressa to 7,000 from 15,000.
Icotinib, another lung cancer drug made by China's Betta Pharmaceuticals, will come down to 5,500 from 12,000 yuan a month.
In exchange for the negotiated price reductions, drug companies can expect to sell much bigger volumes in the cost-conscious Chinese healthcare system.

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

The growing pains of mobile health

The growing pains of mobile health | Healthcare: reloaded... | Scoop.it
While countless companies have emerged with important missions that are solving real problems, there could be serious implications when these technologies and businesses are not vetted properly. Plenty of companies have rushed to market — claiming to screen for cancer or decrease depression, only to be proven wrong or inconsistent — using unverified methods or a loophole to make claims that the technology can’t back up.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Innovators vs. the establishment extends to digital health

Innovators vs. the establishment extends to digital health | Healthcare: reloaded... | Scoop.it
Just like in the presidential campaign, a new guard is rising up against the establishment in digital health — and healthcare in general. Entrenched interests, of course, are fighting back any way they can to retain their grip on the industry.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Autologous Hematopoietic Stem Cell Transplant (HCST)

Autologous Hematopoietic Stem Cell Transplant (HCST) | Healthcare: reloaded... | Scoop.it
Autologous hematopoietic stem cell transplant (AHSCT, often shortened to HSCT) is a procedure where human stem cells are harvested from the patient and stored with the goal of restarting the patient’s immune system after it has been destroyed by chemotherapy along with or without radiotherapy.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Is High Prescription Drug Spending Becoming Our New Normal?

Is High Prescription Drug Spending Becoming Our New Normal? | Healthcare: reloaded... | Scoop.it
Lately it seems as if specialty drugs are everywhere. While it used to be that only a small number of patients were treated using these expensive drugs, manufacturers are increasingly developing specialty products to treat conditions that affect much larger populations over a longer period of time.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Bringing Innovation to Patients: Merck Presents New Advances at ASCO 2016

Bringing Innovation to Patients: Merck Presents New Advances at ASCO 2016 | Healthcare: reloaded... | Scoop.it
Merck, a leading science and technology company, announced that this year's Annual Meeting of the American Society of Clinical Oncology (ASCO; June 3-7, 2016, Chicago, IL, U.S.) will feature research on Merck compounds across a broad range of cancers. These reports, which focus on cancers with significant unmet patient need, will inform and advance scientific knowledge within the oncology community. This includes data on avelumab*, Merck's high priority, late-stage investigational immuno-therapy, that is being developed in collaboration with Pfizer.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Acupuncture Practice Expands The Brain Discovery

Acupuncture Practice Expands The Brain Discovery | Healthcare: reloaded... | Scoop.it
Ordinarily, studies focus on the effects of acupuncture on patients. Now, researchers have made an intensive investigation of the effects of the profession on brain neuroplasticity in this controlled experiment. The MRI data demonstrates distinct brain development as a result of the professional acupuncturist experience. The study explores how the brain responds to daily activities in an effort to develop enhanced therapeutic rehabilitation and training techniques for widespread applications.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Blockchain applications for healthcare

Blockchain applications for healthcare | Healthcare: reloaded... | Scoop.it
Health information exchanges (HIE) and all-payer claim databases (APCD) have become obsolete with blockchain. It doesn't make sense to trust organizations to verify member's trustworthiness when it's not required with blockchain. Eliminating this prehistoric middleman increases data security and removes the cost, time, and resources required to prove that a party is doing what they say they'll do. New models that share medical records are emerging.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Gene therapy may give way to new type I diabetes treatment

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Despite eclectic ways of delivering insulin to c
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

ACT Health targets toddlers and families through social media for vaccine trial

ACT Health targets toddlers and families through social media for vaccine trial | Healthcare: reloaded... | Scoop.it

ACT Health has targeted parents and mothers networks via social media to participate in a clinical trial without disclosing its partnership with a major pharmaceutical company.
The Facebook post aimed to recruit 18-24 month old toddlers for a study of a new Meningococcal B vaccine.

more...
No comment yet.